Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Cash from Investing Activities (2016 - 2025)

National Healthcare (NHC) has disclosed Cash from Investing Activities for 16 consecutive years, with -$12.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 11.07% year-over-year to -$12.9 million, compared with a TTM value of -$33.9 million through Dec 2025, up 85.7%, and an annual FY2025 reading of -$33.9 million, up 85.7% over the prior year.
  • Cash from Investing Activities was -$12.9 million for Q4 2025 at National Healthcare, down from $2.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $2.8 million in Q4 2022 and bottomed at -$224.1 million in Q3 2024.
  • Average Cash from Investing Activities over 5 years is -$18.0 million, with a median of -$5.9 million recorded in 2021.
  • Peak annual rise in Cash from Investing Activities hit 273.78% in 2024, while the deepest fall reached 4263.35% in 2024.
  • Year by year, Cash from Investing Activities stood at -$13.1 million in 2021, then soared by 121.7% to $2.8 million in 2022, then crashed by 459.68% to -$10.2 million in 2023, then decreased by 14.32% to -$11.6 million in 2024, then decreased by 11.07% to -$12.9 million in 2025.
  • Business Quant data shows Cash from Investing Activities for NHC at -$12.9 million in Q4 2025, $2.0 million in Q3 2025, and -$15.6 million in Q2 2025.